The 145th Annual Meeting of the Pharmaceutical Society of Japan (Fukuoka)
Advanced Search

Session Details

Oral Presentation(A) Pharmaceutical Chemistry

[28-13-am]Drug Discovery, SAR 2

Fri. Mar 28, 2025 2:45 PM - 4:26 PM JST
Fri. Mar 28, 2025 5:45 AM - 7:26 AM UTC
Room 13 (Fukuoka International Congress Center: 402+403 [4F])
Chair: Suzuki Takayoshi, Shigehiro Kawashima
2:45 PM - 2:57 PM JST(5:45 AM - 5:57 AM UTC)

[28-13-pm08]Investigation of the antimicrobial activity of Trp-Pro-Arg-myticalin A6 (3–23)-OH derivatives substituted at position 6 and/or 9

○Keiko Okimura1, Tatsuo Takahashi1, Fuka Wakata1, Takuma Kyogaku1, Tohru Daikoku1 (1. Fac. Pharm. Sci., Hokuriku Univ.)
2:57 PM - 3:09 PM JST(5:57 AM - 6:09 AM UTC)

[28-13-pm09S]Structure-Activity Relationship Study of Lipopeptide DDM-838 Presented by CD1a

○Masashi Okmaoto1, Daisuke Morita2, Hiroki Akiba1,3, Akira Hattori1, Norihito Arichi1, Hideaki Kakeya1, Hiroaki Ohno1, Shinsuke Inuki1,4 (1. Grad. Sch. Pharm. Sci., Kyoto Univ., 2. LiMe, Kyoto Univ., 3. NIBIOHN, 4. Grad. Sch. Inst. Biomed. Sci., Tokushima Univ.)
3:09 PM - 3:21 PM JST(6:09 AM - 6:21 AM UTC)

[28-13-pm10S]SAR Study of Pseudouridimycin

○Ryotaro Okawa1, Courtney C Aldrich2, Satoshi Ichikawa1 (1. Grad. Sch. Pharm. Sci., Hokkaido Univ., 2. Minnesota Univ.)
3:21 PM - 3:33 PM JST(6:21 AM - 6:33 AM UTC)

[28-13-pm11S]Synthesis and Structure-Activity Relationship Studies of Novel Balanol Analogs: Efficient construction of 4-benzoyl benzoate part A

○Shogo Naka1, Hiroaki Asashita1, Kenji Arimitsu1, Naoyoshi Maezaki1, Yoshimi Hirokawa1 (1. Faculty of Pharm., Osaka Ohtani Univ.)
3:33 PM - 3:38 PM JST(6:33 AM - 6:38 AM UTC)

Break

3:38 PM - 3:50 PM JST(6:38 AM - 6:50 AM UTC)

[28-13-pm12S]Structure-activity relationship studies of SARS-CoV-2 main protease inhibitors focused on fluorine substitutions

○Ryusei Yamamoto1, Nobuyo Higashi-Kuwata2, Kohei Tsuji1, Takuya Kobayakawa1, Takahiro Ishii1, Kouki Shinohara1, Shin-ichiro Hattori2, Naoki Kishimoto3, Nobutoki Takamune3, Shogo Misumi3, Haydar Bulut4, Hironori Hayashi5, Hiroaki Mitsuya2,4, Hirokazu Tamamura1 (1. Laboratory for Biomaterials and Bioengineering, Institute of Science Tokyo, 2. Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, 3. Department of Environmental and Molecular Health Science, Faculty of Life Science , Kumamoto University, 4. National Cancer Institute, National Institutes of Health, 5. International Research Institute of Disaster Science, Tohoku University)
3:50 PM - 4:02 PM JST(6:50 AM - 7:02 AM UTC)

[28-13-pm13S]Design and synthesis of novel protease inhibitors against both SARS-CoV-2 and Mpox virus

○Kouki Shinohara1, Takuya Kobayakawa1, Yuki Takamatu2, Kohei Tsuji1, Hiroaki Mitsuya2,3,4, Hirokazu Tamamura1 (1. Laboratory for Biomaterials and Bioengineering, Institute of Science Tokyo, 2. National Center for Global Health and Medicine Research Institute, 3. Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, 4. Kumamoto University Hospital)
4:02 PM - 4:14 PM JST(7:02 AM - 7:14 AM UTC)

[28-13-pm14S]Development of Functionalized Molecule for SARS-CoV-2 3CL Protease-Selective Photooxygenation

○Shuko Amber Murano1, Kaoru Ikekawa1, Hideyuki Okamoto1,2, Yuki Yamauchi1, Sho Konno1,2, Akihiro Taguchi1,2, Atsuhiko Taniguchi1,2, Yoshio Hayashi1,3 (1. Grad. Sch. Pharm., Tokyo Univ. Pharm. Life Sci., 2. Sch. Pharm., Tokyo Univ. Pharm. Life Sci., 3. Sch. Life Sci., Tokyo Univ. Pharm. Life Sci.)
4:14 PM - 4:26 PM JST(7:14 AM - 7:26 AM UTC)

[28-13-pm15S]Development of paclitaxel-based anticancer prodrugs targeting biomarker enzyme activity

○Seiryo Murakami1, Kyohhei Fujita2, Yasuteru Urano1,2 (1. Grad. Sch. Pharm. Sci., Tokyo Univ., 2. Grad. Sch. Med., Tokyo Univ.)
Back to Category List